Advanced search
Publication Cover
Leukemia & Lymphoma Volume 49, 2008 - Issue 9
Submit an article Journal homepage
167
Views
15
CrossRef citations to date
0
Altmetric
Original Articles Clinical

Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic leukemia: analysis after a minimum follow-up of 5 years

Pankaj Malhotra Division of Hematology, Mayo Clinic, Rochester, MN, USA
,
William J. Hogan Division of Hematology, Mayo Clinic, Rochester, MN, USACorrespondence[email protected]
,
Mark R. Litzow Division of Hematology, Mayo Clinic, Rochester, MN, USA
,
Michelle A. Elliott Division of Hematology, Mayo Clinic, Rochester, MN, USA
,
Dennis A. Gastineau Division of Hematology, Mayo Clinic, Rochester, MN, USA
,
Stephen M. Ansell Division of Hematology, Mayo Clinic, Rochester, MN, USA
,
Angela Dispenzieri Division of Hematology, Mayo Clinic, Rochester, MN, USA
,
Morie A. Gertz Division of Hematology, Mayo Clinic, Rochester, MN, USA
,
Suzanne R. Hayman Division of Hematology, Mayo Clinic, Rochester, MN, USA
,
David J. Inwards Division of Hematology, Mayo Clinic, Rochester, MN, USA
,
Martha Q. Lacy Division of Hematology, Mayo Clinic, Rochester, MN, USA
,
Ivana N. Micallef Division of Hematology, Mayo Clinic, Rochester, MN, USA
,
Luis F. Porrata Division of Hematology, Mayo Clinic, Rochester, MN, USA
&
Ayalew Tefferi Division of Hematology, Mayo Clinic, Rochester, MN, USA
 show all
Pages 1724-1730 | Received 03 Apr 2008, Accepted 09 Jun 2008, Published online: 01 Jul 2009

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Maciej Machaczka, Jan-Erik Johansson, Mats Remberger, Helene Hallböök, Claes Malm, Vladimir Lj Lazarevic, Anders Wahlin, Hamdy Omar, Gunnar Juliusson, Eva Kimby & Hans Hägglund. (2012) Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival?. Leukemia & Lymphoma 53:9, pages 1699-1705.
Read now
Leslie A Andritsos & Michael R Grever. (2011) Salvage therapy for relapsed chronic lymphocytic leukemia. Expert Review of Hematology 4:2, pages 199-212.
Read now

Articles from other publishers (13)

Mohamed A. Kharfan-Dabaja, Nour Moukalled, Tea Reljic, Jessica El-Asmar & Ambuj Kumar. (2018) Reduced intensity is preferred over myeloablative conditioning allogeneic HCT in chronic lymphocytic leukemia whenever indicated: A systematic review/meta-analysis. Hematology/Oncology and Stem Cell Therapy 11:2, pages 53-64.
Crossref
Mohamed A. Kharfan-Dabaja, Ambuj Kumar, Mehdi Hamadani, Stephan Stilgenbauer, Paolo Ghia, Claudio Anasetti, Peter Dreger, Emili Montserrat, Miguel-Angel Perales, Edwin P. Alyea, Farrukh T. Awan, Ernesto Ayala, Jacqueline C. Barrientos, Jennifer R. Brown, Januario E. Castro, Richard R. Furman, John Gribben, Brian T. Hill, Mohamad Mohty, Carol Moreno, Susan O'Brien, Steven Z. Pavletic, Javier Pinilla-Ibarz, Nishitha M. Reddy, Mohamed Sorror, Christopher Bredeson, Paul Carpenter & Bipin N. Savani. (2016) Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation 22:12, pages 2117-2125.
Crossref
Anthony Mato & David L. Porter. (2015) A drive through cellular therapy for CLL in 2015: allogeneic cell transplantation and CARs. Blood 126:4, pages 478-485.
Crossref
Uri RozovskiOhad BenjaminiPreetesh JainPhilip A. ThompsonWilliam G. WierdaSusan O'BrienJan A. BurgerAlessandra FerrajoliStefan FaderlElizabeth ShpallChitra HosingIssa F. KhouriRichard ChamplinMichael J. KeatingZeev Estrov. (2015) Outcomes of Patients With Chronic Lymphocytic Leukemia and Richter's Transformation After Transplantation Failure. Journal of Clinical Oncology 33:14, pages 1557-1563.
Crossref
Josephine N Emole, Frederick L Locke & Javier Pinilla-Ibarz. (2015) An update on current and prospective immunotherapies for chronic lymphocytic leukemia. Immunotherapy 7:4, pages 455-466.
Crossref
Ronald M. Sobecks, Jose F. Leis, Robert Peter Gale, Kwang Woo Ahn, Xiaochun Zhu, Mitchell Sabloff, Marcos de Lima, Jennifer R. Brown, Yoshihiro Inamoto, Gregory A. Hale, Mahmoud D. Aljurf, Rammurti T. Kamble, Jack W. Hsu, Steven Z. Pavletic, Baldeep Wirk, Matthew D. Seftel, Ian D. Lewis, Edwin P. Alyea, Jorge Cortes, Matt E. Kalaycio, Richard T. Maziarz & Wael Saber. (2014) Outcomes of Human Leukocyte Antigen–Matched Sibling Donor Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia: Myeloablative Versus Reduced-Intensity Conditioning Regimens. Biology of Blood and Marrow Transplantation 20:9, pages 1390-1398.
Crossref
Rohtesh S. Mehta, Antonio Di Stasi, Chitra Hosing, Nina Shah, Katayoun Rezvani, Amin Alousi, Susan O'Brien, William Wierda, Michael Keating & Elizabeth J. Shpall. (2014) Lenalidomide-Induced Graft-Vs.-Leukemia Effect in a Patient With Chronic Lymphocytic Leukemia Who Relapsed After Allogeneic Stem Cell Transplant. Clinical Lymphoma Myeloma and Leukemia 14:3, pages e105-e109.
Crossref
Marcie Riches Tomblyn. (2014) Reprint of: A Review of Cellular Therapies for Chronic Lymphocytic Leukemia. Biology of Blood and Marrow Transplantation 20:2, pages S18-S21.
Crossref
Marcie Riches Tomblyn. (2014) A Review of Cellular Therapies for Chronic Lymphocytic Leukemia. Biology of Blood and Marrow Transplantation 20:2, pages 164-167.
Crossref
Deepesh P. Lad, Pankaj Malhotra & Subhash Varma. (2012) Chronic Lymphocytic Leukemia: Inception to Cure: Are We There?. Indian Journal of Hematology and Blood Transfusion 29:1, pages 1-10.
Crossref
Mohamed A. Kharfan-DabajaAli Bazarbachi. (2012) Hematopoietic Stem Cell Allografting for Chronic Lymphocytic Leukemia: A Focus on Reduced-Intensity Conditioning Regimens. Cancer Control 19:1, pages 68-75.
Crossref
Robert Quan Le, Margaret Bevans, Bipin N. Savani, Sandra A. Mitchell, Kate Stringaris, Eleftheria Koklanaris & A. John Barrett. (2010) Favorable Outcomes in Patients Surviving 5 or More Years after Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies. Biology of Blood and Marrow Transplantation 16:8, pages 1162-1170.
Crossref
Julio DelgadoDonald W. Milligan & Peter Dreger. (2009) Allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: ready for prime time?. Blood 114:13, pages 2581-2588.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.